{"paper_id":"78663e55-27bb-4ef7-80eb-88b53d6f2743","body_text":"Case Reports\nVol. 6 (2016)\nAromatase inhibitor therapy in a cystic fibrosis patient with thoracic endometriosis\nPublisher's note\nAll claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.\nAll claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.\nReceived: 17 February 2016\nPublished: 8 November 2016\nPublished: 8 November 2016\n1413\nViews\n718\nDownloads\nDownloads\nDownload data is not yet available.\nHow to Cite\nAromatase inhibitor therapy in a cystic fibrosis patient with thoracic endometriosis. (2016). Chest Disease Reports, 6(1). https://doi.org/10.4081/cdr.6.5815\nPAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.","source_license":"CC0","license_restricted":false}